Glycogen synthase kinase 3 beta inhibitor SB216763 improves Kir2.1 expression after myocardia infraction in rats

ConclusionsGSK-3 β inhibition upregulates Kir2.1 expression in a rat model of MI.
Source: Journal of Interventional Cardiac Electrophysiology - Category: Cardiology Source Type: research